- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 82.61M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 82.61M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 80.88M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.94K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$40.34K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $151 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $144 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$76.07K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$12.07K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $22.15K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $107.65K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $132K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $86.62K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $132K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $86.62K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $27.29K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $45.75K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $55.94K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $74.56K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $45.42K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $65.99K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$63.67K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$85.96K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$63.42K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$83.99K |